Nicox provides clinical and regulatory update for NCX 4251 in blepharitis
Jan 05, 2017 06:34 am UTC| Business
Press Release Nicox provides clinical and regulatory update for NCX 4251 in blepharitis Pre-IND meeting on NCX 4251 with FDA completed Phase 2 expected to start Q4 2017 January 5, 2017 ...
Nidec Announces the Status of Own Share Repurchase
Jan 05, 2017 06:30 am UTC| Business
KYOTO, Japan, Jan. 05, 2017 -- Nidec Corporation (TSE:6594) (OTC US:NJDCY) (the “Company”) today announced the status of the Company’s own share repurchase under its ongoing repurchase plan resolved at a meeting of the...
Jan 05, 2017 06:21 am UTC| Business
Valneva SE ("Valneva" or "the Company"), a fully integrated, commercial stage biotech company focused on developing innovative life-saving vaccines, today announced that it has signed a research license agreement with MSD...
ABLYNX TO PRESENT AT THE 35th ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Jan 05, 2017 06:19 am UTC| Business
Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] will present at the 35th Annual J.P. Morgan Healthcare Conference on Wednesday 11 January 2017 at 4:30 p.m. Pacific Standard Time (1.30 a.m. on Thursday 12 January, Central...
Targovax announces appointment of Erik Digman Wiklund as CFO
Jan 05, 2017 06:13 am UTC| Business
Oslo, Norway, 5 January 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that Erik Digman Wiklund has...
Uganda speeds visa issuance and strengthens border security with Gemalto Visa Management System
Jan 05, 2017 06:00 am UTC| Business
Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, is supplying Uganda’s Directorate of Citizenship and Immigration Control (DCIC) with its Coesys Visa Management that combines swift issuance of all...
Celyad Announces Registration of the first patient in the Belgian THINK trial
Jan 05, 2017 06:00 am UTC| Business
A first colorectal cancer patient has been registered at Institut Jules Bordet.CAR-T NKR-2 processing started yesterday at Celyad’s manufacturing facility, in Mont-Saint-Guibert. MONT-SAINT-GUIBERT, Belgium, Jan. 05,...